CARE TO CONTRIBUTE?
TIPS, COMMENTS and QUESTIONS are always welcome (and strictly confidential).
Contact The Daily Caveat via:
Or just
read the feed...
Previous Posts
- FSA Fines Deutsche Bank on Scania Purchase Misconduct
- Global Macro Funds Expanding Rapidly, Hurting for ...
- Another Investigative Firm in Hot Water in Bermuda...
- Milberg Indictments Still Sought in Kickback Inves...
- SEC Charges Two with Stock Fraud
- And Speaking of Refco, Another Fund Manager has Be...
- Refco Short-Sellers Face SEC Charges
- Punitive Phase of Trial Ahead for Merck in Vioxx Case
- Equity Investment Research Budgets Getting Slashed
- Hedge Fund Activism a Growing Trend?
4/11/2006
Jury Awards $9.5 million in Punitive Damages to Plaintiff in Vioxx Trial
Jury Awards $9.5 million in Punitive Damages to Plaintiff in Vioxx Trial
Last week we saw a split decision, with one of two Vioxx plaintiffs moving on to the punitive damages. Today the numbers are in and the jury in the New Jersey case has awarded John McDarby $9.5 million in punitive damages relating to claims that Merck's Vioxx drug contributed a heart attack suffered by McDarby.
Well, for Merck, that's one down 10,000 to go... More here.
-- MDT
Well, for Merck, that's one down 10,000 to go... More here.
-- MDT
0 Comments.
Post a Comment
